dc.contributor.author |
Palpatzis, Eleni |
dc.contributor.author |
Akinci, Muge |
dc.contributor.author |
Aguilar Dominguez, Pablo |
dc.contributor.author |
Garcia Prat, Marina |
dc.contributor.author |
Blennow, Kaj |
dc.contributor.author |
Zetterberg, Henrik |
dc.contributor.author |
Carboni, Margherita |
dc.contributor.author |
Kollmorgen, Gwendlyn |
dc.contributor.author |
Wild, Norbert |
dc.contributor.author |
Fauria, Karine |
dc.contributor.author |
Falcón, Carles |
dc.contributor.author |
Gispert López, Juan Domingo |
dc.contributor.author |
Suárez-Calvet, Marc |
dc.contributor.author |
Grau-Rivera, Oriol |
dc.contributor.author |
Sánchez Benavides, Gonzalo |
dc.contributor.author |
Arenaza Urquijo, Eider M. |
dc.contributor.author |
ALFA Study |
dc.date.accessioned |
2024-07-01T06:42:21Z |
dc.date.available |
2024-07-01T06:42:21Z |
dc.date.issued |
2024 |
dc.identifier.citation |
Palpatzis E, Akinci M, Aguilar-Dominguez P, Garcia-Prat M, Blennow K, Zetterberg H, et al. Lifetime stressful events associated with Alzheimer's Pathologies, neuroinflammation and brain structure in a risk enriched cohort. Ann Neurol. 2024 Jun;95(6):1058-68. DOI: 10.1002/ana.26881 |
dc.identifier.issn |
0364-5134 |
dc.identifier.uri |
http://hdl.handle.net/10230/60614 |
dc.description.abstract |
Objective: Along with the known effects of stress on brain structure and inflammatory processes, increasing evidence suggest a role of chronic stress in the pathogenesis of Alzheimer's disease (AD). We investigated the association of accumulated stressful life events (SLEs) with AD pathologies, neuroinflammation, and gray matter (GM) volume among cognitively unimpaired (CU) individuals at heightened risk of AD. Methods: This cross-sectional cohort study included 1,290 CU participants (aged 48-77) from the ALFA cohort with SLE, lumbar puncture (n = 393), and/or structural magnetic resonance imaging (n = 1,234) assessments. Using multiple regression analyses, we examined the associations of total SLEs with cerebrospinal fluid (1) phosphorylated (p)-tau181 and Aβ1-42/1-40 ratio, (2) interleukin 6 (IL-6), and (3) GM volumes voxel-wise. Further, we performed stratified and interaction analyses with sex, history of psychiatric disease, and evaluated SLEs during specific life periods. Results: Within the whole sample, only childhood and midlife SLEs, but not total SLEs, were associated with AD pathophysiology and neuroinflammation. Among those with a history of psychiatric disease SLEs were associated with higher p-tau181 and IL-6. Participants with history of psychiatric disease and men, showed lower Aβ1-42/1-40 with higher SLEs. Participants with history of psychiatric disease and women showed reduced GM volumes in somatic regions and prefrontal and limbic regions, respectively. Interpretation: We did not find evidence supporting the association of total SLEs with AD, neuroinflammation, and atrophy pathways. Instead, the associations appear to be contingent on events occurring during early and midlife, sex and history of psychiatric disease. ANN NEUROL 2024;95:1058-1068. |
dc.description.sponsorship |
The research leading to these results has received funding by the Ministry of Science and Innovation (PID2019-111514RA-I00) and the Alzheimer's Association research grants (AARG 2019-AARG-644641, AARG 2019-AARG-644641-RAPID), to EMA-U. EMA-U is supported by the Spanish Ministry of Science and Innovation—State Research Agency (RYC2018-026053-I), co-funded by the European Social Fund (ESF). EP is funded by the Spanish Ministry of Science and Innovation (PRE2020-095827). This work has received funding from “la Caixa” Foundation (ID 100010434), under agreement LCF/PR/GN17/50300004 and the Alzheimer's Association and an international anonymous charity foundation through the TriBEKa Imaging Platform project (TriBEKa-17-519007). Additional support has been received from the Universities and Research Secretariat, Ministry of Business and Knowledge of the Catalan Government under the grant no. 2021 SGR 00913. MS-C is funded by a fellowship from “la Caixa” Foundation (ID 100010434). OG-R is supported by the Spanish Ministry of Science and Innovation—State Research Agency (IJC2020-043417-I/MCIN/AEI/10.13039/501100011033) and the European Union «NextGenerationEU»/PRTR. The Roche NeuroToolKit is a panel of robust prototype assays used for investigational purposes only and not approved for clinical use. COBAS and ELECSYS are trademarks of Roche. |
dc.format.mimetype |
application/pdf |
dc.language.iso |
eng |
dc.publisher |
Wiley |
dc.relation.ispartof |
Ann Neurol. 2024 Jun;95(6):1058-68 |
dc.rights |
© 2024 Barcelonabeta Brain Research Center and The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
dc.rights.uri |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.subject.other |
Alzheimer, Malaltia d' |
dc.subject.other |
Estrès |
dc.title |
Lifetime stressful events associated with Alzheimer's Pathologies, neuroinflammation and brain structure in a risk enriched cohort |
dc.type |
info:eu-repo/semantics/article |
dc.identifier.doi |
http://dx.doi.org/10.1002/ana.26881 |
dc.relation.projectID |
info:eu-repo/grantAgreement/ES/2PE/PID2019-111514RA-I00 |
dc.rights.accessRights |
info:eu-repo/semantics/openAccess |
dc.type.version |
info:eu-repo/semantics/publishedVersion |